Product Information

BUPROPION HCL XL 450 MG TABLET is a generic product labeled by Alvogen Inc., priced at $7.5194 per EA under NDC 47781063730. Its NADAC has been published 332 times since Oct 23, 2019.

The High Outlier badge above means this manufacturer's average price in the bupropion hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

BUPROPION HCL XL 450 MG TABLET

bupropion hydrochloride
$7.5194per EA
Discontinued
High Outlier

Strength

450 mg/1

Manufacturer

Alvogen Inc.

NDC

47781063730

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

2/18/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA022497

On Market Since

9/28/2018

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL XL 450 MG TABLET has been published 332 times since Oct 23, 2019, and over the history we have for it it has declined 19.7%. The table below summarizes its recorded NADAC range and movement.

Current price$7.5194 per EA
All-time high$11.1049 (May 13, 2020)
All-time low$5.5246 (Nov 20, 2024)
52-week high$8.3176
52-week low$6.0148
Median price$8.6581
Average price$8.4214
Largest weekly change+33.5% (Jun 19, 2024)
Weeks tracked332
Tracking sinceOct 23, 2019

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-6.9%

1Y

+25.0%

3Y

-12.6%

5Y

-23.5%

All

-19.7%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUPROPION HCL XL 450 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 450 MG TABLET, manufactured by Alvogen Inc., is $7.5194 per EA (NDC 47781063730), effective Feb 25, 2026.

How has the price of BUPROPION HCL XL 450 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL XL 450 MG TABLET has declined 19.7%. It has been tracked across 332 weekly CMS publications since Oct 23, 2019.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 450 MG TABLET?

Since Oct 23, 2019, the NADAC for BUPROPION HCL XL 450 MG TABLET has ranged from a low of $5.5246 (Nov 20, 2024) to a high of $11.1049 (May 13, 2020), with a median of $8.6581 per EA.

Are there cheaper alternatives to BUPROPION HCL XL 450 MG TABLET?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as BUPROPION HCL XL 450 MG TABLET, but none are currently priced below it.

Who manufactures BUPROPION HCL XL 450 MG TABLET?

BUPROPION HCL XL 450 MG TABLET (NDC 47781063730) is labeled by Alvogen Inc., and CMS classifies it as a generic product.